Department of Urology, Davis School of Medicine, University of California, Sacramento, CA, USA.
Department of Urology, San Diego School of Medicine, University of California, La Jolla, CA, USA.
Curr Urol Rep. 2024 Nov 5;26(1):16. doi: 10.1007/s11934-024-01234-4.
Transgender and non-binary patients (TGNB) undergoing gender affirming genital surgery may experience perioperative voiding dysfunction. This review aims to outline and analyze literature about gender affirming pelvic surgery urinary complications, evaluation, and treatment.
If a patient is seeking bottom surgery, then urinary goals and pre-operative symptoms should be discussed with respect to variable post-operative outcomes. Urologists should also be aware of the effect that gender affirming hormone therapy has on urinary symptoms. Urethral strictures and urethrocutaneous fistulae occur after feminizing and masculinizing procedures and may manifest as LUTS. Although there is no standardized approach for managing post-operative voiding issues, we present available options. The evaluation of TGNB patients is ideally affirming and tailored to the patient. Long-term urinary and voiding outcomes measurements after vaginoplasty and phalloplasty are also needed, as current validated questionnaires do not capture these symptoms well in TGNB patients.
接受性别肯定生殖器手术的跨性别和非二进制患者 (TGNB) 可能经历围手术期排尿功能障碍。本综述旨在概述和分析关于性别肯定骨盆手术尿并发症、评估和治疗的文献。
如果患者正在寻求下体手术,那么应根据不同的术后结果讨论与尿相关的目标和术前症状。泌尿科医生还应了解性别肯定激素治疗对尿症状的影响。尿道狭窄和尿道皮肤瘘在女性化和男性化手术后发生,可能表现为 LUTS。尽管没有标准化的方法来管理术后排尿问题,但我们提出了可用的选择。TGNB 患者的评估理想上是肯定的,并根据患者量身定制。还需要对阴道成形术和阴茎成形术的长期尿和排尿结局进行测量,因为目前的有效问卷并不能很好地捕捉 TGNB 患者的这些症状。